DailyStocks Stock Article Search

https://www.zacks.com/stock/news/2202697/astrazeneca-azn-set-to-acquire-gracell-for-1-2-billion?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2202697 Dec 27, 2023 - AstraZeneca (AZN) is set to acquire clinical-stage biopharmaceutical company, Gracell, for a total deal value of up to $1.2 billion. 0

https://www.zacks.com/stock/news/2204045/here-s-how-much-a-1000-investment-in-abbvie-made-10-years-ago-would-be-worth-today?cid=CS-ZC-FT-tale_of_the_tape|investing_$1000-2204045 Jan 01, 2024 - Investing in certain stocks can pay off in the long run, especially if you hold on for a decade or more. 0

https://www.zacks.com/stock/news/2205271/abbvie-abbv-rises-as-market-takes-a-dip-key-facts?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_6-2205271 Jan 03, 2024 - AbbVie (ABBV) closed the most recent trading day at $160.46, moving +0.4% from the previous trading session. 0

https://www.zacks.com/stock/news/2207004/abbvie-abbv-now-trades-above-golden-cross-time-to-buy?cid=CS-ZC-FT-tale_of_the_tape|golden_crossover-2207004 Jan 08, 2024 - Should investors be excited or worried when a stock's 50 -day simple moving average crosses above the 200-day simple moving average? 0

https://www.zacks.com/commentary/2210770/q4-earnings-season-scorecard-and-analyst-reports-for-apple-abbvie-toyota?cid=CS-ZC-FT-research_daily-2210770 Jan 16, 2024 - Today's Research Daily features a real-time update on the Q4 earnings season and new research reports on Apple (AAPL), AbbVie (ABBV), Toyota Motor (TM) and others. 0

https://www.zacks.com/commentary/2224591/top-stock-reports-for-abbvie-applied-materials-american-express?cid=CS-ZC-FT-research_daily-2224591 Feb 12, 2024 - Today's Research Daily features new research reports on 16 major stocks, including AbbVie Inc. (ABBV), Applied Materials, Inc. (AMAT) and American Express Company (AXP). 0

https://www.zacks.com/stock/news/2227354/ironwood-irwd-q4-earnings-miss-revenues-beat-marginally?cid=CS-ZC-FT-analyst_blog|earnings_article-2227354 Feb 16, 2024 - Ironwood's (IRWD) fourth-quarter 2023 earnings lag estimates while revenues beat the same marginally. Linzess collaboration revenues drive the top line. 0

https://www.zacks.com/stock/news/2229455/abbvie-abbv-announces-appointment-of-new-ceo-robert-michael?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2229455 Feb 21, 2024 - Robert Michael is set to succeed Richard A. Gonzalez as AbbVie's (ABBV) CEO, effective Jul 1, 2024. 0

https://www.zacks.com/commentary/2242883/top-analyst-reports-for-mastercard-abbvie-salesforce?cid=CS-ZC-FT-research_daily-2242883 Mar 19, 2024 - Today's Research Daily features new research reports on 16 major stocks, including Mastercard Incorporated (MA), AbbVie Inc. (ABBV) and Salesforce, Inc. (CRM). 0

https://www.zacks.com/stock/news/2247400/pharma-stock-roundup-abbv-nvo-s-new-m-as-fda-nod-to-jnj-mrk-pah-drugs?cid=CS-ZC-FT-analyst_blog|stock_roundup-2247400 Mar 28, 2024 - While AbbVie (ABBV) is set to buy Landos Biopharma, Novo Nordisk (NVO) is set to acquire Cardior Pharmaceuticals. FDA approves J&J's (JNJ) and Merck's (MRK) PAH drugs. 0